Hasil Pencarian - Funda Meric‐Bernstam

Perbaiki Hasil
  1. 1
    BREAST CONSERVING SURGERY IN LOCALLY ADVANCED BREAST CANCER

    BREAST CONSERVING SURGERY IN LOCALLY ADVANCED BREAST CANCER oleh Funda Meriç Bernstam

    Diterbitkan 2006-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    SENTINEL LYMPH NODE DISSECTION CONTROVERSIES

    SENTINEL LYMPH NODE DISSECTION CONTROVERSIES oleh Funda Meriç Bernstam

    Diterbitkan 2005-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    BREAST-CONSERVING THERAPY

    BREAST-CONSERVING THERAPY oleh Funda Meriç Bernstam

    Diterbitkan 2005-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Whole Genome Sequencing in Cancer Clinics

    Whole Genome Sequencing in Cancer Clinics oleh Ken Chen, Funda Meric-Bernstam

    Diterbitkan 2015-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Reconstructing mutational lineages in breast cancer by multi-patient-targeted single-cell DNA sequencing

    Reconstructing mutational lineages in breast cancer by multi-patient-targeted single-cell DNA sequencing oleh Jake Leighton, Min Hu, Emi Sei, Funda Meric-Bernstam, Nicholas E. Navin

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Strategies for improving the management of immune-related adverse events

    Strategies for improving the management of immune-related adverse events oleh Gennaro Ciliberto, Aung Naing, Funda Meric-Bernstam, Michael B Atkins, Joud Hajjar

    Diterbitkan 2020-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Antibody-drug conjugates in lung cancer: dawn of a new era?

    Antibody-drug conjugates in lung cancer: dawn of a new era? oleh Niamh Coleman, Timothy A. Yap, John V. Heymach, Funda Meric-Bernstam, Xiuning Le

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    CanDrA: cancer-specific driver missense mutation annotation with optimized features.

    CanDrA: cancer-specific driver missense mutation annotation with optimized features. oleh Yong Mao, Han Chen, Han Liang, Funda Meric-Bernstam, Gordon B Mills, Ken Chen

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    CombPDX: a unified statistical framework for evaluating drug synergism in patient-derived xenografts

    CombPDX: a unified statistical framework for evaluating drug synergism in patient-derived xenografts oleh Licai Huang, Jing Wang, Bingliang Fang, Funda Meric-Bernstam, Jack A. Roth, Min Jin Ha

    Diterbitkan 2022-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Nanogrid single-nucleus RNA sequencing reveals phenotypic diversity in breast cancer

    Nanogrid single-nucleus RNA sequencing reveals phenotypic diversity in breast cancer oleh Ruli Gao, Charissa Kim, Emi Sei, Theodoros Foukakis, Nicola Crosetto, Leong-Keat Chan, Maithreyan Srinivasan, Hong Zhang, Funda Meric-Bernstam, Nicholas Navin

    Diterbitkan 2017-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    397 Intra-tumor immunotherapy injections utilizing image guidance in interventional radiology: clinical trial experience at a tertiary care cancer center

    397 Intra-tumor immunotherapy injections utilizing image guidance in interventional radiology: clinical trial experience at a tertiary care cancer center oleh Sanjay Gupta, Vivek Subbiah, Sapna Patel, Adi Diab, Ravi Murthy, Aung Naing, Funda Meric-Bernstam, Filip Janku, Alda Tam, Timothy Yap, Rahul Sheth

    Diterbitkan 2020-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Molecular differences between younger versus older ER-positive and HER2-negative breast cancers

    Molecular differences between younger versus older ER-positive and HER2-negative breast cancers oleh Tao Qing, Thomas Karn, Mariya Rozenblit, Julia Foldi, Michal Marczyk, Naing Lin Shan, Kim Blenman, Uwe Holtrich, Kevin Kalinsky, Funda Meric-Bernstam, Lajos Pusztai

    Diterbitkan 2022-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Emergence of mTOR mutation as an acquired resistance mechanism to AKT inhibition, and subsequent response to mTORC1/2 inhibition

    Emergence of mTOR mutation as an acquired resistance mechanism to AKT inhibition, and subsequent response to mTORC1/2 inhibition oleh Niamh Coleman, Vivek Subbiah, Shubham Pant, Keyur Patel, Sinchita Roy-Chowdhuri, Sireesha Yedururi, Amber Johnson, Timothy A. Yap, Jordi Rodon, Kenna Shaw, Funda Meric-Bernstam

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Cancer driver mutation prediction through Bayesian integration of multi-omic data.

    Cancer driver mutation prediction through Bayesian integration of multi-omic data. oleh Zixing Wang, Kwok-Shing Ng, Tenghui Chen, Tae-Beom Kim, Fang Wang, Kenna Shaw, Kenneth L Scott, Funda Meric-Bernstam, Gordon B Mills, Ken Chen

    Diterbitkan 2018-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    143 Correlating RNA-seq detection and IHC staining of potential antibody-drug conjugate (ADC) targets: HER3, HER2, TROP2, Nectin4, and aFLR

    143 Correlating RNA-seq detection and IHC staining of potential antibody-drug conjugate (ADC) targets: HER3, HER2, TROP2, Nectin4, and aFLR oleh Funda Meric-Bernstam, Nathan Fowler, Ekaterina Postovalova, Zhongmin Xiang, Krystle Nomie, Vladimir Kushnarev, Alexander Bagaev, Danil Stupichev, Kirill Kryukov, Suren Davitavyan, Monique Johnson, Basavaraja Uddajjara Shanthappa

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Phase 1 trial of ADI‐PEG 20 and liposomal doxorubicin in patients with metastatic solid tumors

    Phase 1 trial of ADI‐PEG 20 and liposomal doxorubicin in patients with metastatic solid tumors oleh Shuyang Yao, Filip Janku, Kimberly Koenig, Apostolia Maria Tsimberidou, Sarina Anne Piha‐Paul, Nai Shi, John Stewart, Amanda Johnston, John Bomalaski, Funda Meric‐Bernstam, Siqing Fu

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Clinically relevant inflammatory breast cancer patient-derived xenograft-derived ex vivo model for evaluation of tumor-specific therapies.

    Clinically relevant inflammatory breast cancer patient-derived xenograft-derived ex vivo model for evaluation of tumor-specific therapies. oleh Bedrich L Eckhardt, Maria Gagliardi, LaKesla Iles, Kurt Evans, Cristina Ivan, Xiuping Liu, Chang-Gong Liu, Glauco Souza, Arvind Rao, Funda Meric-Bernstam, Naoto T Ueno, Geoffrey A Bartholomeusz

    Diterbitkan 2018-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Adaptive Darwinian off-target resistance mechanisms to selective RET inhibition in RET driven cancer

    Adaptive Darwinian off-target resistance mechanisms to selective RET inhibition in RET driven cancer oleh Vivek Subbiah, Mohamed A. Gouda, J. Bryan Iorgulescu, Ramona Dadu, Keyur Patel, Steven Sherman, Maria Cabanillas, Mimi Hu, Luz E. Castellanos, Behrang Amini, Funda Meric-Bernstam, Tao Shen, Jie Wu

    Diterbitkan 2024-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials

    Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials oleh Roman Groisberg, David S. Hong, Amini Behrang, Kenneth Hess, Filip Janku, Sarina Piha-Paul, Aung Naing, Siqing Fu, Robert Benjamin, Shreyaskumar Patel, Neeta Somaiah, Anthony Conley, Funda Meric-Bernstam, Vivek Subbiah

    Diterbitkan 2017-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    584 Phase I/II study to evaluate the safety and tolerability of avelumab in combination with other anti-cancer therapies in patients with advanced malignancies

    584 Phase I/II study to evaluate the safety and tolerability of avelumab in combination with other anti-cancer therapies in patients with advanced malignancies oleh Aung Naing, Funda Meric-Bernstam, Shubham Pant, Milind Javle, Juhee Song, Anas Alshawa, Bettzy Stephen, Abdulrazzak Zarifa, Jordi Rodon, Yali Yang, Robert A Wolff, Anne Knisely, Van Morris, Jibran Ahmed

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: